Mycoses: all 260 studies

Page 2 of 3. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• The Role of Interferon-gamma in Immune Responses to Invasive CandidiasisCompletedNCT05235711
• An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal InfectionCompletedNCT05202366
• Relationship Between Fungal Colonization and Severe Bronchopulmonary DysplasiaCompletedNCT05152875
• Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant PatientsCompletedNCT05150327
• Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult SubjectsCompletedNCT04872231Phase 1
• COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)CompletedNCT04818853
• A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy MalesCompletedNCT04804059Phase 1
• Fungal Infection in Patients in Intensive Care UnitsStatus unknownNCT04684342Not applicable
• Emerging Invasive Fungal Infections in Critically Ill PatientsCompletedNCT04647539
• Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With AsthmaCompletedNCT04576325Phase 1
• Immune Profiles in CF Fungal InfectionCompletedNCT04476758
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 3
• Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in InfantsCompletedNCT04351685Phase 3
• ADME Study of [14C]-Ibrexafungerp in Healthy Male SubjectsCompletedNCT04307082Phase 1
• Point-of-care Tests for Bacterial Vaginosis and CandidosisStatus unknownNCT04287504
• Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT04273178Phase 2
• Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry FeetCompletedNCT04265521Not applicable
• Microbiota in Skin and Mucosa of Patients With Inflammatory Skin DiseasesStatus unknownNCT04215458Not applicable
• A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the ToenailCompletedNCT04188574Phase 2
• A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001CompletedNCT04166669Phase 1
• Anti-fungal Strategies in Acute-on-Chronic Liver Failure PatientsCompletedNCT04157465Not applicable
• Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral AdministrationCompletedNCT04122560Phase 4
• Fungal Infection in Patients With Diabetic Foot OsteomyelitisStatus unknownNCT04041739
• Study to Optimize the Use of New AntibioticsStatus unknownNCT03941951Not applicable
• A Study of Itraconazole in the Management of Superficial Fungal Infections in IndiaTerminatedNCT03923010Phase 4
• Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using CaspofunginCompletedNCT03857399Phase 2
• Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes OnychomycosisCompletedNCT03814343Phase 4
• fungalAi for Fungal Surveillance & Antifungal StewardshipStatus unknownNCT03793231
• A Study to Evaluate the Appropriateness of the Voriconazole Dosing RegimenCompletedNCT03760276Phase 1
• CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood LevelsCompletedNCT03731169Phase 4
• Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in ChinaStatus unknownNCT03676777
• Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.Status unknownNCT03674359
• Efflux Pump Mediated Azole Resistance in Candida AlbicansStatus unknownNCT03659162
• Fungal Infections in Patients With Hematological MalignanciesStatus unknownNCT03650439
• Ampholipad Real-World Data in TaiwanCompletedNCT03641131
• Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung TransplantStatus unknownNCT03561415Phase 2
• Impact of Genotyping P450 2C19 on Hospitalization PeriodWithdrawnNCT03554239Not applicable
• Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With PosaconazoleCompletedNCT03434704Phase 2
• Descriptive Epidemiology on Management of MucormycosisCompletedNCT03429023
• Pharmacokinetics of CaspofunginCompletedNCT03399032
• Non-inferiority Trial of Dapaconazole Versus KetoconazoleCompletedNCT03320486Phase 3
• NLA101 in Adults Receiving High Dose Chemotherapy for AMLTerminatedNCT03301597Phase 2
• Systemic Fungal Infections in ICU PatientsStatus unknownNCT03292224
• Vietnam Cryptococcal Retention in Care Study - Version 2.1Status unknownNCT03267407
• The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.Status unknownNCT03260634
• Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal KeratitisStatus unknownNCT03230058Phase 2/3
• Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic InfectionsTerminatedNCT03159364Phase 1/2
• PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.CompletedNCT03121235
• Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.CompletedNCT03005353Phase 2/3
• Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered OrallyCompletedNCT02957929Phase 1
• Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy SubjectsCompletedNCT02956499Phase 1
• the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With PerforationsCompletedNCT02941068Phase 2
• Etiologies, Investigations and Outcomes of Patients Presenting With HemoptysisStatus unknownNCT02913365
• Pharmacokinetics of Two Different Formulation of VoriconazoleCompletedNCT02912156Phase 4
• Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida ColonizationCompletedNCT02888197
• Sautour PHRC IR 2008CompletedNCT02859831
• Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte OnychomycosisCompletedNCT02812043Phase 4
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast InfectionsCompletedNCT02733432Phase 2
• Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora ColonisationCompletedNCT02730494Phase 1
• Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and OutcomeCompletedNCT02683642
• Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular MethodStatus unknownNCT02676570
• Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and DermatophytosisCompletedNCT02582177Phase 3
• Granulocyte Transfusions in Hematological Patients With Febrile NeutropeniaCompletedNCT02544230
• Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar TherapyTerminatedNCT02445235
• Genetic Variation and Variability in Posaconazole Pharmacokinetics in ChildrenCompletedNCT02358499Phase 1
• MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic TrialCompletedNCT02306330Not applicable
• Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal CandidiasisCompletedNCT02251093Phase 3
• MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant PatientsCompletedNCT02227797Phase 1
• Endoscopic Surgical Treatment of Rhino-Sinusal MucormycosisTerminatedNCT02226705Not applicable
• Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)CompletedNCT02154178Not applicable
• Effect of Inflammation on Voriconazole ConcentrationCompletedNCT02074462
• Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or SepsisCompletedNCT02025699
• Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill PatientsCompletedNCT01866020
• Bioequivalence Study for Terbinafine 250 mgCompletedNCT01772212Phase 1
• A Study of Empirical Antifungal Therapy With ItraconazoleCompletedNCT01706562
• Registry of Febrile Neutropenia and Invasive Fungal InfectionsStatus unknownNCT01684189
• Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)Status unknownNCT01490138
• Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)CompletedNCT01436578
• Pharmacokinetic Analysis of Posaconazole in Lung Transplant RecipientsCompletedNCT01419678Not applicable
• Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell TransplantationStatus unknownNCT01417169Phase 2
• Perception and Prevalence of Fungal Infections in Berlin - BrandenburgCompletedNCT01393002
• Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal ProphylaxisCompletedNCT01318148Phase 2
• Pre-hospital Risk Factors for Invasive Fungal InfectionStatus unknownNCT01315925
• Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsCompletedNCT01303549Phase 4
• Empirical Versus Preemptive Antifungal TherapyCompletedNCT01288378Phase 3
• Caspofungin as Prophylaxis in High Risk Liver Transplantation RecipientsStatus unknownNCT01260974Phase 2
• Prospective Population Study on Candidemia in SpainCompletedNCT01236261
• Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO)CompletedNCT01169402Phase 1
• A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical SubjectsCompletedNCT01122368Phase 2
• Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal InfectionsStatus unknownNCT01105013Phase 3
• Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous DialysisCompletedNCT01101386
• Liver Transplant European Study Into the Prevention of Fungal InfectionCompletedNCT01058174Phase 3
• Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual OnychomycosisCompletedNCT01044381Phase 1/2
• Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic OnychomycosisStatus unknownNCT01014637Phase 4
• Neurodevelopmental Outcomes and Fluconazole ProphylaxisCompletedNCT00975949
• Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary ZygomycosisCompletedNCT00923832
• Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian CentersCompletedNCT00906633
• Therapeutic Drug Monitoring of VoriconazoleCompletedNCT00890708Not applicable
• Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal InfectionsCompletedNCT00876096Not applicable
• Alternate Day Micafungin: A PK Study in Pediatric PatientsCompletedNCT00842504Phase 1

← Mycoses overview